Regulatory Mechanism of PD-L1 Expression in Primary Liver Cancer
The application of immunotherapy has become a hot spot in tumor research currently. In particular, immune checkpoint inhibitors have played an important role in the treatment of advanced unresectable primary liver cancer. However, the efficacy of immune checkpoint inhibitors varies greatly in the tr...
Saved in:
Main Authors: | LI Shenghao, SHI Xinli |
---|---|
Format: | article |
Language: | ZH |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/aeb6ca2b49204a9f9fbb56777e5f963a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
by: Zhitao Li, et al.
Published: (2021) -
Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
by: Xiangdong Ye, et al.
Published: (2021) -
Visual Analysis and Focused Areas of Immunotherapy for Liver Cancer Based on Literature Data
by: YANG Xi, et al.
Published: (2021) -
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
by: Jianyu Liu, et al.
Published: (2021) -
Dl-3-N-Butylphthalide Presents Anti-Cancer Activity in Lung Cancer by Targeting PD-1/PD-L1 Signaling
by: Jiang Q, et al.
Published: (2021)